Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 3;64(4):3176.
doi: 10.4081/ejh.2020.3176.

Heterotopic ossification in a patient with diffuse idiopathic skeletal hyperostosis: Input from histological findings

Affiliations

Heterotopic ossification in a patient with diffuse idiopathic skeletal hyperostosis: Input from histological findings

Caterina Licini et al. Eur J Histochem. .

Abstract

A high incidence of heterotopic ossification (HO) has been reported in patients with diffuse idiopathic skeletal hyperostosis (DISH), a metabolic disease characterized by calcifications of entheses at spine and peripheral sites. We performed histological and immunohistochemical analyses in five different HO sites in a patient with DISH to study a possible mutual interaction of bone morphogenetic protein 2 (BMP-2), transforming growth factor beta (TGF-β), and decorin, crucial for bone mass increasing, matrix calcification, and endochondral bone formation. We speculated that the surgical trauma triggered HO, inducing TGF-β release at the lesion site. TGF-β recruits osteoblast precursor cells and determines the overexpression of BMP-2 in the surrounding skeletal muscle, inducing a further osteogenic differentiation, contributing to HO onset.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Radiological and CT evidence of HO around the hip. A) Pre-operative X-rays image showing bridging ossification along T10, T11 and T12 vertebrae. B,C) Pre-operative CT images; IP, ilio-psoas; Mg, medius gluteus; Pir, piriformis. D) Pre-operative X-rays image showing HO at right hip. E) X-rays image taken at 1 day after surgery. e) X-rays image taken at 8 weeks after surgery.
Figure 2.
Figure 2.
A-F) Haematoxylin & Eosin staining of HO. A) Compact bone with adjacent cartilage layer. Fibrous tissue and bone marrow are also shown; scale bar 100 μm. B) Ossification site; scale bar 50 μm. C) Muscular and fibrous tissues adjacent to bone; scale bar 100 μm. D) Compact bone; scale bar 100 μm. E) Trabecular bone; scale bar 100 μm).F) Particular of ossification site, black arrowheads indicate osteoclasts; scale bar 10 μm. G-I) Toluidine Blue staining; blue colour indicates high proteoglycan content. G) Compact bone with adjacent cartilage layer; scale bar 100 μm. H) Compact bone; scale bar 100 μm. I) Particular of compact bone; scale bar 50 μm. J-L) Safranin O staining; red colour indicates high proteoglycan content. J) Compact bone with adjacent cartilage layer; scale bar 100 μm. K) Compact bone; scale bar 100 μm. L) Particular of compact bone; scale bar 50 μm; W, woven bone; L, lamellar bone; B, bone; C, cartilage; BM, bone marrow; M, muscular tissue; F, fibrous tissue; OS, ossification site.
Figure 3.
Figure 3.
A) Immunohistochemical analysis of BMP-2, TGF-beta and decorin in healthy and HO tissues; scale bar 50 μm; BMP-2 staining in (a) healthy lamellar bone, (b) HO lamellar and woven bone (W), and (c) representative histogram of BMP-2 expression (**p<0.01); BMP-2 expression in (d) healthy and e) HO muscular tissue, and (f ) representative histogram of BMP-2 expression (**p<0.01); TGF-beta staining in (g) healthy lamellar bone (arrowheads), (h) HO woven and lamellar bone (arrowheads), and (i) representative histogram of TGF-beta expression; decorin expression in (j) healthy lamellar bone, (k) HO woven (W) and lamellar bone, and (l) representative histogram of decorin expression (**p<0.01). B) BMP-2, TGF-beta and decorin staining in cartilage tissue in HO; a) at the ossification site (OS), BMP-2 expression in cartilage, chondrocytes and osteoclast (arrowheads) in cartilage; b) at the ossification site (OS), TGF-beta expression in cartilage and chondrocytes; c) at the ossification site (OS), decorin expression in cartilage and chondrocytes.

References

    1. Vasileiadis GI, Amanatullah DF, Crenshaw JR, Taunton MJ, Kaufman KR. Effect of heterotopic ossification on hip range of motion and clinical outcome. J Arthroplasty 2015;30:461–4. - PubMed
    1. Mader R, Verlaan J-J, Buskila D. Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nat Rev Rheumatol 2013;9:741–50. - PubMed
    1. Fournier DE, Kiser PK, Beach RJ, Dixon SJ, Seguin CA. Dystrophic calcification and heterotopic ossification in fibrocartilaginous tissues of the spine in diffuse idiopathic skeletal hyperostosis (DISH). Bone Res 2020;8:1–10. - PMC - PubMed
    1. Belanger TA, Rowe DE. Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg 2001;9:258-67. - PubMed
    1. Mader R, Verlaan J-J, Eshed I, Bruges-Armas J, Puttini PS, Atzeni F, et al. Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next. RMD Open. 2017;3:e000472. - PMC - PubMed

MeSH terms